News MedTech Barcelona

Stay informed with the latest insights, research, and developments

Barcelona – Singapore– MedTech Barcelona is strengthening its international presence through a strategic distribution partnership with i-DNA Biotechnologies, significantly expanding access to its cutting-edge ready-to-use cell-based assay kits and room-temperature shipping technologies across Southeast Asia. This collaboration represents a pivotal step in MedTech Barcelona’s mission to bring innovative in vitro

As 2025 comes to an end, MedTech Barcelona looks back on a year defined by growth and scientific progress. Over the past twelve months, we strengthened our global presence, expanded our product portfolio, and connected with researchers and partners across multiple continents. What follows is a recap of the initiatives

At MedTech Barcelona, we were proud to support and participate in the 12th edition of BIOSPAIN 2025, held in Barcelona, Spain’s leading hub for biotechnology and life sciences. This year’s event once again positioned the city as the country’s epicenter of scientific innovation, offering a vibrant space for collaboration, knowledge

MedTech Barcelona shares key highlights from ISSX 2025 in Chicago, advancing in vitro innovation with ready-to-use cell kits and room-temperature shipping.
MedTech Barcelona introduces Custom Cell Plates. This solution provides study-ready cultures prepared with the client’s selected cell line and supplied in the required quantities and frequency. MedTech Barcelona’s proprietary room-temperature shipping technology enables worldwide delivery within 48–96 hours. The objective is straightforward: ensure dependable access to plated cells, reduce variability

The landscape of drug discovery and development is undergoing rapid transformation. Over the last decade, significant efforts have been directed toward the design of in vitro cell culture assays capable of providing more accurate predictions of drug efficacy and safety. As a result, biotech companies and academic institutions are increasingly

MedTech Barcelona is expanding its portfolio with new solutions in cellular biotechnology that meet industry needs and strengthen its position in biomedical and pharmaceutical research. Following the acquisition of ReadyCell S.L., a leading provider of ready-to-use cell kits and pioneer of a unique technology for room-temperature cell shipment, MedTech Barcelona

From July 16–17, 2025, MedTech Barcelona took part in the Spain–Singapore Business Summit, an international event organized by ICEX, the Spain Chamber of Commerce, and the Spanish Embassy in Singapore, with the support of the Singapore Economic Development Board (EDB), Enterprise Singapore, and the Singapore Business Federation (SBF), and co-financed

From 16–19 June 2025, MEDTECH BARCELONA had the privilege of participating in the BIO International Convention in Boston, one of the world's leading events in biotechnology and life sciences. With over 20,000 attendees and more than 1,500 exhibitors from across the globe, BIO Boston offered an extraordinary opportunity to showcase

We’re excited to unveil the new website of MedTech Barcelona — a platform that not only showcases a renewed visual identity but also reflects our broader mission and international outlook. As of October 2024, the company officially transitioned into MedTech Barcelona, a Leitat-owned biotech company dedicated to innovation in the

Blog

Filter by Category

Filter by Tags

Sign up for MedTech Newsletter

Stay updated with the latest news, updates, and special offers. Join our community by signing up for our newsletter today!